Medpace Holdings Statistics
Total Valuation
MEDP has a market cap or net worth of $9.52 billion. The enterprise value is $9.00 billion.
| Market Cap | 9.52B |
| Enterprise Value | 9.00B |
Important Dates
The next confirmed earnings date is Monday, April 21, 2025, after market close.
| Earnings Date | Apr 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MEDP has 30.47 million shares outstanding. The number of shares has increased by 0.54% in one year.
| Current Share Class | 30.47M |
| Shares Outstanding | 30.47M |
| Shares Change (YoY) | +0.54% |
| Shares Change (QoQ) | -0.67% |
| Owned by Insiders (%) | 19.36% |
| Owned by Institutions (%) | 85.12% |
| Float | 24.55M |
Valuation Ratios
The trailing PE ratio is 24.73 and the forward PE ratio is 25.27. MEDP's PEG ratio is 3.43.
| PE Ratio | 24.73 |
| Forward PE | 25.27 |
| PS Ratio | 4.58 |
| Forward PS | 4.31 |
| PB Ratio | 11.56 |
| P/TBV Ratio | 73.90 |
| P/FCF Ratio | 16.63 |
| P/OCF Ratio | 15.63 |
| PEG Ratio | 3.43 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.90, with an EV/FCF ratio of 15.72.
| EV / Earnings | 22.25 |
| EV / Sales | 4.27 |
| EV / EBITDA | 18.90 |
| EV / EBIT | 20.13 |
| EV / FCF | 15.72 |
Financial Position
The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.18.
| Current Ratio | 0.93 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | 0.26 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 58.42% and return on invested capital (ROIC) is 32.89%.
| Return on Equity (ROE) | 58.42% |
| Return on Assets (ROA) | 14.87% |
| Return on Invested Capital (ROIC) | 32.89% |
| Return on Capital Employed (ROCE) | 44.85% |
| Revenue Per Employee | $357,467 |
| Profits Per Employee | $68,533 |
| Employee Count | 5,900 |
| Asset Turnover | 1.12 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MEDP has paid $71.54 million in taxes.
| Income Tax | 71.54M |
| Effective Tax Rate | 15.03% |
Stock Price Statistics
The stock price has decreased by -22.54% in the last 52 weeks. The beta is 1.47, so MEDP's price volatility has been higher than the market average.
| Beta (5Y) | 1.47 |
| 52-Week Price Change | -22.54% |
| 50-Day Moving Average | 335.83 |
| 200-Day Moving Average | 355.73 |
| Relative Strength Index (RSI) | 38.81 |
| Average Volume (20 Days) | 384,308 |
Short Selling Information
The latest short interest is 1.24 million, so 4.08% of the outstanding shares have been sold short.
| Short Interest | 1.24M |
| Short Previous Month | 1.46M |
| Short % of Shares Out | 4.08% |
| Short % of Float | 5.06% |
| Short Ratio (days to cover) | 3.19 |
Income Statement
In the last 12 months, MEDP had revenue of $2.11 billion and earned $404.34 million in profits. Earnings per share was $12.63.
| Revenue | 2.11B |
| Gross Profit | 1.43B |
| Operating Income | 446.87M |
| Pretax Income | 397.17M |
| Net Income | 404.34M |
| EBITDA | 476.12M |
| EBIT | 446.87M |
| Earnings Per Share (EPS) | $12.63 |
Balance Sheet
The company has $669.44 million in cash and $149.52 million in debt, giving a net cash position of $519.91 million or $17.06 per share.
| Cash & Cash Equivalents | 669.44M |
| Total Debt | 149.52M |
| Net Cash | 519.91M |
| Net Cash Per Share | $17.06 |
| Equity (Book Value) | 825.55M |
| Book Value Per Share | 27.01 |
| Working Capital | -75.32M |
Cash Flow
In the last 12 months, operating cash flow was $608.82 million and capital expenditures -$36.55 million, giving a free cash flow of $572.27 million.
| Operating Cash Flow | 608.82M |
| Capital Expenditures | -36.55M |
| Free Cash Flow | 572.27M |
| FCF Per Share | $18.78 |
Margins
Gross margin is 67.66%, with operating and profit margins of 21.19% and 19.17%.
| Gross Margin | 67.66% |
| Operating Margin | 21.19% |
| Pretax Margin | 22.57% |
| Profit Margin | 19.17% |
| EBITDA Margin | 22.58% |
| EBIT Margin | 21.19% |
| FCF Margin | 27.13% |
Dividends & Yields
MEDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.54% |
| Shareholder Yield | n/a |
| Earnings Yield | 4.25% |
| FCF Yield | 6.01% |
Analyst Forecast
The average price target for MEDP is $373.22, which is 19.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $373.22 |
| Price Target Difference | 19.48% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 10.60% |
| EPS Growth Forecast (5Y) | 10.62% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MEDP has an Altman Z-Score of 7 and a Piotroski F-Score of 6.
| Altman Z-Score | 7 |
| Piotroski F-Score | 6 |